Marché mondial des dispositifs de traitement du diabète – Tendances et prévisions du secteur jusqu’en 2031

Analyse et taille du marché des dispositifs de traitement du diabète

Plusieurs facteurs stimulent la croissance du marché des dispositifs de traitement du diabète, notamment la prévalence croissante du diabète dans le monde, en particulier dans les économies émergentes. L'augmentation des taux d'obésité, les habitudes alimentaires malsaines et les modes de vie sédentaires contribuent à l'incidence croissante du diabète, ce qui entraîne une demande accrue de dispositifs de traitement du diabète. Des innovations telles que les systèmes de surveillance continue du glucose (CGM), les pompes à insuline et les stylos à insuline intelligents améliorent la gestion du diabète et la qualité de vie des patients. Ces dispositifs offrent des moyens plus précis et plus pratiques de surveiller la glycémie et d'administrer l'insuline, ce qui conduit à de meilleurs résultats pour les patients.

Français La taille du marché mondial des dispositifs de soins du diabète était évaluée à 31,54 milliards USD en 2023 et devrait atteindre 61,47 milliards USD d'ici 2031, avec un TCAC de 8,7 % au cours de la période de prévision de 2024 à 2031. En plus des informations sur les scénarios de marché tels que la valeur marchande, le taux de croissance, la segmentation, la couverture géographique et les principaux acteurs, les rapports de marché organisés par Data Bridge Market Research comprennent également une analyse approfondie des experts, l'épidémiologie des patients, l'analyse du pipeline, l'analyse des prix et le cadre réglementaire.

Portée du rapport et segmentation du marché       

Market Definition

Diabetes care devices are medical devices designed to help individuals manage their diabetes. These devices include blood glucose meters, continuous glucose monitors (CGMs), insulin pumps, insulin pens, insulin syringes, and insulin jet injectors. They are used to monitor blood glucose levels, administer insulin, and manage the condition to prevent complications. These devices play a crucial role in managing diabetes, helping individuals maintain optimal blood glucose levels and improve their quality of life.                

Diabetes Care Devices Market Dynamics

Drivers

• Rising Diabetes Prevalence

The escalating global prevalence of diabetes, especially in emerging economies, due to sedentary lifestyles, poor dietary habits, and increasing obesity rates contribute to the rising incidence of diabetes, fueling the demand for diabetes care devices. As per the National Center for Biotechnology Information (NCBI) report in October 2023, if current trends persist, over half of the global population will be overweight or obese by 2035, with a majority of new diabetes cases being type 2 diabetes, largely due to changes in obesity rates and dietary habits. As the number of diabetes cases continues to increase, the market for devices that assist in managing the condition is expanding rapidly, driving the market growth.

• Technological Advancements

Continual advancements in diabetes care devices, such as continuous glucose monitoring systems, insulin pumps, and smart insulin pens, offer enhanced accuracy, convenience, and efficiency in diabetes management, leading to greater patient acceptance. The evolution of these devices is revolutionizing diabetes care, making it easier and more effective to manage the condition, and driving up adoption rates globally.

Opportunities

• Telemedicine and Remote Monitoring  

The increasing adoption of telemedicine and remote monitoring technologies enables healthcare providers to remotely monitor patients' glucose levels and adjust treatment plans accordingly, enhancing patient care and convenience. Effective communication between patients and healthcare providers leads to improved diabetes management and better patient outcomes. It presents significant opportunities for diabetes care device manufacturers.         

• Integrated Healthcare Systems  

Seamless integration allows for the efficient sharing of patient information among healthcare providers, ensuring that patients receive comprehensive and coordinated care. Integrated healthcare systems also enable healthcare professionals to access real-time data from diabetes care devices, allowing for more informed decision-making and personalized treatment plans. Integrating diabetes care devices with healthcare systems and electronic health records (EHRs) offers opportunities for market growth.

Restraints/Challenges

• Limited Access to Healthcare

In rural and remote areas, diagnosis and treatment of diabetes can be hindered, leading to suboptimal management of the condition. Improving access to healthcare is crucial to address this challenge and increase the adoption of diabetes care devices. Limited access to healthcare services poses a significant challenge to the diabetes care devices market.

• High Cost of Devices

The affordability of these devices is a key consideration for patients, and cost-effective solutions are needed to address this challenge. Manufacturers must work to develop devices that are not only effective but also affordable, ensuring that they are accessible to a wider range of patients. The high cost of diabetes care devices can be a barrier to access for many patients, especially those in developing economies.

This diabetes care devices market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the diabetes care devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

• In May 2023, Medtronic agreed to acquire EOFlow, a manufacturer of insulin devices. The integration of EOFlow with Medtronic's Meal Detection Technology algorithm and advanced continuous glucose monitor (CGM) is expected to enhance the company's ability to serve a broader range of people with diabetes
• In April 2023, Undbio announced its plan to invest USD 100 million in constructing a US-based insulin manufacturing plant. The South Korean company intends to build a new facility in West Virginia to manufacture insulin and distribute its products within the country
• In July 2023, CharmHealth and Bioverge jointly invested in My Diabetes Tutor, a startup focused on improving the lives of individuals with diabetes

Diabetes Care Devices Market Scope

The diabetes care devices market is segmented on the basis of product type, device type, delivery type, and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Type

• Blood Glucose Monitoring Devices
• Testing Strips
• Blood Glucose Meters
• Self-monitoring Blood Glucose Meters
• Continuous Blood Glucose Monitoring Devices
• Lancets
• Others
• Insulin Delivery Devices

Device Type

• Self-monitoring
• Diagnostic

Delivery Type

• Pumps
• Pen
• Syringes
• Injectors
• Cartridges in Reusable pens
• Disposable Pens
• Jet Injectors

 Distribution Channel

• Institutional Sales
• Hospitals
• Clinics
• Others
• Retail Sales
• Hospital pharmacies
•  Retail pharmacies
• Online pharmacies

Diabetes Care Devices Market Regional Analysis/Insights

The diabetes care devices market is analyzed and market size insights and trends are provided by country, product type, device type, delivery type, and distribution channel as referenced above.

The countries covered in the market are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina, and Rest of South America.

North America is expected to dominate the market due to several factors, including the increasing geriatric population, the rising burden of diabetes due to lifestyle changes, the growing prevalence of obesity, and the high cost of treatment. In addition, the presence of market leaders such as Abbott, Medtronic, Dexcom, and Insulet Corporation, with their operational headquarters in this region, is contributing to the market's growth. 

Asia-Pacific is expected to witness significant growth during the forecast period due to the presence of major market players and the increasing prevalence of diabetes in the region. Furthermore, advancements in blood glucose monitoring devices, a growing geriatric population, and the rising incidence of lifestyle diseases such as obesity are expected to drive the market growth.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Croissance de la base installée des infrastructures de santé et pénétration des nouvelles technologies

Le marché des dispositifs de soins du diabète vous fournit également une analyse détaillée du marché pour chaque pays, la croissance des dépenses de santé pour les équipements en capital, la base installée de différents types de produits pour le marché des dispositifs de soins du diabète, l'impact de la technologie à l'aide de courbes de vie et les changements dans les scénarios réglementaires des soins de santé et leur impact sur le marché des dispositifs de soins du diabète. Les données sont disponibles pour la période historique 2011-2021.

Analyse du paysage concurrentiel et des parts de marché des dispositifs de traitement du diabète

Le paysage concurrentiel du marché des dispositifs de soins du diabète fournit des détails par concurrent. Les détails inclus sont la présentation de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements dans la recherche et le développement, les nouvelles initiatives du marché, la présence mondiale, les sites et installations de production, les capacités de production, les forces et les faiblesses de l'entreprise, le lancement du produit, la largeur et l'étendue du produit, la domination des applications. Les points de données ci-dessus fournis ne concernent que l'orientation des entreprises par rapport au marché.

Certains des principaux acteurs opérant sur le marché sont :

• Abbott (États-Unis)
• PHC Holdings Corporation (Japon)
• WellDoc, Inc (Inde)
• Sanofi (France)
• Dexcom, Inc (États-Unis)
• DarioHealth Corp. (États-Unis)
• Medtronic (Irlande)
• B. Braun SE (Allemagne)
• F. Hoffmann-La Roche SA (Suisse)
• Insulet Corporation (États-Unis)
• Ascensia Diabetes Care Holdings AG (Suisse)
• Tidepool (États-Unis)
• Medtronic (Irlande)
• Tandem Diabetes Care (États-Unis)
• LifeScan (États-Unis)
• AgaMatrix (États-Unis)
• Glooko Inc. (États-Unis)
• DarioHealth (Israël)

SKU-1586